Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Singh D., Nicolini G., Bindi E., Corradi M., Guastalla D., Kampschulte J., Pierzchala W., SAYINER A., Szilasi M., Terzano C., et al.

doi:10.1186/1471-2466-14-43

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Singh D., Nicolini G., Bindi E., Corradi M., Guastalla D., Kampschulte J., et al.

BMC PULMONARY MEDICINE, cilt.14, 2014

Cilt numarası: 14
Basım Tarihi: 2014
Doi Numarası: 10.1186/1471-2466-14-43
Dergi Adı: BMC PULMONARY MEDICINE

Özet

Background: The study evaluated the efficacy of beclomethasone dipropionate/formoterol fumarate (BDP/FF) extrafine combination versus fluticasone propionate/salmeterol (FP/S) combination in COPD patients.